Integrated community case management (iCCM) of malaria, pneumonia, and diarrhea has been increasingly adopted as a strategy to improve the access of children to treatment of these diseases in underserved areas. iCCM offers a way forward both from the perspective of the sick child and from the perspective of rational drug use, by providing diagnosticsguided, evidence-based treatment of the sick child. Attesting to the importance of this approach, a United Nations Children's Fund/World Health Organization (UNICEF/WHO) joint statement justifying the need for iCCM and making recommendations on its implementation was released this year and republished in this special supplement. 1 However, there are many facets to this approach that need to be optimized for iCCM to have the greatest impact on morbidity and mortality of children less than five years of age. Well-designed implementation research and rigorous monitoring and evaluation of programs have been and will continue to be important sources of evidence for improvement of iCCM policies and program implementation.
A 3 Many of the studies reported in this supplement were designed to fill in the research knowledge gaps identified by CCM.ORG and are ready to be shared with the wider CCM community. However, there remain many gaps in our understanding of the optimal approaches to the implementation, scale-up, and sustainability of iCCM programs, and new questions have arisen.
For example, there remain many questions on the effect of iCCM on community health workers, including their capacity to absorb increasing amounts and complexity of disease management tasks, their role in surveillance and reporting of routine disease burden from the community level, optimal approaches for supervision, and the best strategies for remuneration (Table 1) . 4 There is also a need for more data on the impact of iCCM on child health outcomes, both reduction of morbidity and mortality, and the cost-effectiveness of this strategy. Similarly, how can adequate coverage be achieved and how can the private sector be effectively engaged in the delivery of iCCM, and conversely can iCCM bring order to and improve the quality of care in unregulated health markets? 5 Another pressing question is how the diagnosis of respiratory infections requiring antibiotic treatment can be improved. Although we need to better understand how iCCM modifies the use of antimicrobial agents in the community and the related therapeutic outcomes, we also need to monitor for adverse effects of the interventions and to assess the impact on antimicrobial resistance.
As many programs have implemented the use of rapid antigen-based diagnostic tests (RDTs) for malaria, there is a need to assess adherence of community-based health workers to the results given the problematic experiences with health workers at the primary health center level where treatment of malaria is often provided for febrile children and adults with RDT-negative test results. 6, 7 What is the potential contribution of providing enhanced diagnostic and treatment approaches (especially for presumed pneumonia) through iCCM on adherence to RDT test results, rational use of drugs, and quality of care in public as well as private sectors, e.g. the Affordable Medicine Facility-malaria? 8 As iCCM expands, there will be a role to test different algorithms in various ecological and system contexts ( Table 1) . 9 As the safety of treatment of severe disease with simple approaches is demonstrated, there is a need to understand how to scale these up while ensuring quality of care and outcomes. A key challenge will be to understand factors that influence adherence to therapy for malaria, pneumonia, or diarrhea. In addition, because infants in the first two months of life are especially vulnerable, regimens for community-based treatment or the utility of pre-referral therapy for serious infections need to be optimized. Part of the challenge there will be to ensure that mothers and other care providers are able to effectively recognize signs of illness, quickly seek appropriate care, and promptly accept recommended treatment and/or referral.
This special supplement of the American Journal of Tropical Medicine and Hygiene contains a number of excellent studies that fill in some of the gaps in the applied health research agenda for iCCM. The list provided in Table 1 includes a number of topics that were previously identified by CCM.ORG for which adequate evidence does not yet exist, and a number of new questions that have arisen during recent years as iCCM programs have expanded in many countries.
So, what are the next steps? We recommend that the operational and applied health research priorities for iCCM be systematically reviewed and updated using the methods developed by the Child Health and Nutrition Research Initiative. 10 This approach to research priority setting requires a well-defined context, transparent evaluation criteria, and independent input *Address correspondence to Davidson H. Hamer, Center for Global Health and Development, Boston University, Crosstown Third Floor, 801 Massachusetts Avenue, Boston, MA 02118. E-mail: dhamer@bu.edu from investors, technical experts, and other stakeholders. [11] [12] [13] Some elegant examples of the outcome of this approach have been recently published.
14,15 After a re-evaluation of research priorities for iCCM using the Child Health and Nutrition Research Initiative approach, there will be a need for donors, including international development agencies and foundations to provide funding to help address these gaps. Funding for implementation research on iCCM has been inconsistent and at times disappointing. Although it is encouraging that the interest for large-scale iCCM interventions is increasing, the iCCM community should realize there cannot be successful wide-scale iCCM implementation if it is not accompanied and supported by sound and rigorous research because many critical questions remain to be answered. Such research can and should be built into iCCM implementation. The mediumand long-term results of additional delivery science experiments will help inform program, policies, and ultimately improve the health of children living in challenging, resourcepoor environments. 39. Can mHealth applications be used to help family members recognize disease, seek care, and adhere to treatment recommendations? 40. How does prescription of multiple medicines for multiple diseases (e.g., malaria and pneumonia) impact on adherence? 41. What key knowledge and tools can be provided by CHWs to families so they can care for themselves at home in the event of an emergency (home care) in the event that services are not accessible? How can families be best prepared for emergencies and outbreaks? Impact 42. What is the impact of iCCM on health and survival of children? 43. Does iCCM lead to increased penetration in terms of reaching the poor? (effective coverage) 44. What is the impact of iCCM on building community and health system resilience (e.g., coping with an emergency)?
*New additions to the list of research priorities are indicated in bold. iCCM = integrated community case management; CHW = community health worker; RDT = rapid diagnostic test; WHO = World Health Organization.
